These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1553491)

  • 1. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia.
    Sato M; Numachi Y; Hamamura T
    Schizophr Bull; 1992; 18(1):115-22. PubMed ID: 1553491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis.
    Sato M
    Ann N Y Acad Sci; 1992 Jun; 654():160-70. PubMed ID: 1632581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis.
    Sato M; Chen CC; Akiyama K; Otsuki S
    Biol Psychiatry; 1983 Apr; 18(4):429-40. PubMed ID: 6860719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia.
    Yui K; Ikemoto S; Ishiguro T; Goto K
    Ann N Y Acad Sci; 2000 Sep; 914():1-12. PubMed ID: 11085303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic methamphetamine intoxication model of schizophrenia in animals.
    Machiyama Y
    Schizophr Bull; 1992; 18(1):107-13. PubMed ID: 1553490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic schizophrenia-like states in methamphetamine psychosis.
    Tomiyama G
    Jpn J Psychiatry Neurol; 1990 Sep; 44(3):531-9. PubMed ID: 2074612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report.
    Iwanami A; Sugiyama A; Kuroki N; Toda S; Kato N; Nakatani Y; Horita N; Kaneko T
    Acta Psychiatr Scand; 1994 Jun; 89(6):428-32. PubMed ID: 8085475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis.
    Ujike H; Sato M
    Ann N Y Acad Sci; 2004 Oct; 1025():279-87. PubMed ID: 15542728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining vulnerability to schizophrenia in methamphetamine psychosis using exploratory eye movements.
    Mikami T; Naruse N; Fukura Y; Ohkubo H; Ohkubo T; Matsuura M; Moriya H; Nishikawa T; Kojima T
    Psychiatry Clin Neurosci; 2003 Aug; 57(4):433-40. PubMed ID: 12839526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory states in female subjects: susceptibility to psychotic states and implications for relapse of schizophrenia.
    Yui K; Ikemoto S; Goto K; Nishijima K; Yoshino T; Ishiguro T
    Pharmacopsychiatry; 2002 Mar; 35(2):62-71. PubMed ID: 11951147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
    McKetin R; Baker AL; Dawe S; Voce A; Lubman DI
    Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization.
    Yui K; Goto K; Ikemoto S; Ishiguro T; Angrist B; Duncan GE; Sheitman BB; Lieberman JA; Bracha SH; Ali SF
    Mol Psychiatry; 1999 Nov; 4(6):512-23. PubMed ID: 10578232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine psychosis: insights from the past.
    McKetin R
    Addiction; 2018 Aug; 113(8):1522-1527. PubMed ID: 29516555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P300 component of event-related potentials in methamphetamine psychosis and schizophrenia.
    Iwanami A; Suga I; Kaneko T; Sugiyama A; Nakatani Y
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 May; 18(3):465-75. PubMed ID: 8078982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sensitivity to stress in spontaneous recurrence of methamphetamine psychosis: noradrenergic hyperactivity with contribution from dopaminergic hyperactivity.
    Yui K; Goto K; Ikemoto S; Ishiguro T; Kamata Y
    J Clin Psychopharmacol; 2000 Apr; 20(2):165-74. PubMed ID: 10770454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Clinical Features of Methamphetamine Users with Persistent Psychosis and Patients with Schizophrenia.
    Wang LJ; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Chen CK
    Psychopathology; 2016; 49(2):108-15. PubMed ID: 27071042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six months follow-up of patients with methamphetamine psychosis.
    Yeh HS; Lee YC; Sun HJ; Wan SR
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jul; 64(7):388-94. PubMed ID: 11584576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing prefrontal cortical activity during inhibition task in methamphetamine-associated psychosis versus schizophrenia: a multi-channel near-infrared spectroscopy study.
    Okada N; Takahashi K; Nishimura Y; Koike S; Ishii-Takahashi A; Sakakibara E; Satomura Y; Kinoshita A; Takizawa R; Kawasaki S; Nakakita M; Ohtani T; Okazaki Y; Kasai K
    Addict Biol; 2016 Mar; 21(2):489-503. PubMed ID: 25619621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases.
    Niemi-Pynttäri JA; Sund R; Putkonen H; Vorma H; Wahlbeck K; Pirkola SP
    J Clin Psychiatry; 2013 Jan; 74(1):e94-9. PubMed ID: 23419236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine-induced behavioral sensitization and its implications for relapse of schizophrenia.
    Akiyama K; Kanzaki A; Tsuchida K; Ujike H
    Schizophr Res; 1994 Jun; 12(3):251-7. PubMed ID: 8054317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.